Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PADI1 | Q9ULC6 | 6/20 | 0.60 |
| ▸ | PADI4 | Q9UM07 | 6/20 | 0.60 |
| ▸ | PADI2 | Q9Y2J8 | 4/20 | 0.60 |
| ▸ | PADI3 | Q9ULW8 | 4/20 | 0.60 |
| ▸ | PDE4A | P27815 | 3/20 | 0.60 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.60 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.60 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.60 |
| ▸ | PADI6 | Q6TGC4 | 1/20 | 0.60 |
| ▸ | HPGDS | O60760 | 3/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.46 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.44 |
| ▸ | MMP12 | P39900 | 1/20 | 0.44 |
| ▸ | F10 | P00742 | 1/20 | 0.44 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10946109 | 1.00 | PADI1 (0.60) | PADI1PADI4PADI2PADI3PDE4A | |
| Hydrochloric Acid SCHEMBL29401072 | 0.97 | PADI1 (0.58) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL7925397 | 0.92 | C3AR1 (0.52) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL188589 | 0.92 | C3AR1 (0.52) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL188590 | 0.92 | C3AR1 (0.52) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL10652468 | 0.88 | GRIN1 (0.48) | PADI1PADI4PADI2PADI3PDE4A | |
| Naphthalene SCHEMBL28216957 | 0.88 | C3AR1 (0.49) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL1979577 | 0.88 | PADI4 (0.63) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL20138329 | 0.88 | PADI4 (0.63) | PADI1PADI4PADI2PADI3PDE4A | |
| SCHEMBL1979695 | 0.87 | PADI4 (0.62) | PADI1PADI4PADI2PADI3PDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160333081-A1 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | THE GENERAL HOSPITAL CORPORATION (US) | 2016-11-17 | — | — | US | claimed |
| US-9205069-B2 | Inhibitors of anaphase promoting complex activity | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-12-08 | — | — | US | claimed |
| WO-2015116896-A1 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | THE GENERAL HOSPITAL CORPORATION (US) | 2015-08-06 | — | — | WO | claimed |
| US-20120115948-A1 | INHIBITORS OF ANAPHASE PROMOTING COMPLEX ACTIVITY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2012-05-10 | — | — | US | claimed |
| WO-2010102281-A2 | INHIBITORS OF ANAPHASE PROMOTING COMPLEX ACTIVITY | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-09-10 | — | — | WO | claimed |
| EP-1585485-A2 | COMPOSITIONS FOR THE REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2005-10-19 | — | — | EP | claimed |
| WO-2004064749-A2 | COMPOSITIONS FOR THE REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 2004-08-05 | — | — | WO | claimed |
| US-20040141935-A1 | Reduction of hair growth | GILLETTE COMPANY, THE | 2004-07-22 | — | — | US | claimed |
| EP-0754023-B1 | INHIBITION OF HAIR GROWTH | HANDELMAN JOSEPH H (US) | 1999-05-26 | — | — | EP | claimed |
| EP-0754023-A1 | INHIBITION OF HAIR GROWTH | HANDELMAN, Joseph H. (US) | 1997-01-22 | — | — | EP | claimed |
| US-5468476-A | Enzyme inhibitor | GILLETTE CO., THE | 1995-11-21 | — | — | US | claimed |
| WO-1995024884-A1 | INHIBITION OF HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1995-09-21 | — | — | WO | claimed |
| EP-4620463-A1 | ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION | CUTANEON - Skin & Hair Innovations GmbH (DE) | 2025-09-24 | — | — | EP | disclosed |
| US-20230321122-A1 | ACTIVE AGENT MODULATING THE ACTIVITY OF AN ION CHANNEL FOR USE IN HAIR GROWTH REGULATION | CUTANEON SKIN & HAIR INNOVATIONS GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| EP-3766545-B1 | ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION | CUTANEON SKIN & HAIR INNOVATIONS GMBH (DE) | 2023-08-16 | — | — | EP | disclosed |
| US-20220168206-A1 | ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION | CUTANEON - SKIN & HAIR INNOVATIONS GMBH (DE) | 2022-06-02 | — | — | US | disclosed |
| US-5468476-A | Enzyme inhibitor | GILLETTE CO., THE | 1995-11-21 | — | — | US | disclosed |
| WO-1995024884-A1 | INHIBITION OF HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1995-09-21 | — | — | WO | disclosed |
| US-4521254-A | Cleaning contact lenses with solution of bromelain and carboxypeptidase | ANDERSON SCIENTIFIC INC. | 1985-06-04 | — | — | US | disclosed |
| US-4086136-A | Process for producing a peptide using a serine or thiol proteinase | (ZAIDANHOJIN) SAGAMI CHEMICAL RESEARCH CENTER (JA) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160333081-A1 | TREATMENT OF SEPSIS AND SEPTIC SHOCK | H1-3, EHMT2, H1-4 | PADI1 20/4885PADI4 9/4885PADI2 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.